Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

This NICE Deal Could Foreshadow 2011
Motley Fool
Friday, December 31, 2010 - 10:55am
tags:
NICE, GSK, Pfizer, Human Genome Sciences, Bristol-Myers Squibb, Merck, AstraZeneca, value-based pricing
That's What You Call Product Differentiation?
Motley Fool
Friday, December 31, 2010 - 10:53am
tags:
testosterone, Endo, Abbott Laboratories, Auxilium, Fortesta, Androgel, Testim
2011 Drugmaker M&A Targets
Motley Fool
Friday, December 31, 2010 - 10:00am
tags:
M&A, Pfizer, Merck, Genzyme, Sanofi, JNJ, Crucell, ONYX Pharmaceuticals, Bayer, Momenta, Novartis, GSK, Human Genome Sciences, Vertex Pharmaceuticals, MannKind, Vivus, Savient
Pfizer Diagnoses Fido, Too
Motley Fool
Friday, December 31, 2010 - 9:58am
tags:
animal health, Pfizer, Synbiotics, M&A
A Look At The Drug Makers Of 2010
Investopedia
Friday, December 31, 2010 - 9:56am
tags:
JNJ, Merck, Novartis, Pfizer, Roche
Exclusive: Glaxo’s Witty On Why He Shuns Megadeals
Forbes
Friday, December 31, 2010 - 9:55am
tags:
GSK, Andrew Witty, M&A, Pharma CEOs
What's Next for Achillion Pharma?
Seeking Alpha
Thursday, December 30, 2010 - 11:31am
tags:
Achillion, Gilead Sciences, Bristol-Myers Squibb
Here We Go Again . . . . Amphastar Renews Generic LOVENOX Case Against FDA
FDA Law Blog
Thursday, December 30, 2010 - 11:15am
tags:
Lovenox, generics, Amphastar, Sanofi
The Next $100 Billion Technology Business
Forbes
Thursday, December 30, 2010 - 11:14am
tags:
DNA sequencing
Novavax's Charts Look Healthy
TheStreet.com
Thursday, December 30, 2010 - 11:13am
tags:
Novavax
FDA Delay of MannKind's Inhaled Insulin Is Mostly Positive News
Seeking Alpha
Thursday, December 30, 2010 - 11:12am
tags:
MannKind, FDA, Afrezza, inhaled insulin
Seattle Genetics Looks Attractive on Fundamentals, Pipeline
Seeking Alpha
Thursday, December 30, 2010 - 11:07am
tags:
Seattle Genetics, cancer, monoclonal antibodies
Theravance Evenly Poised
Yahoo/Zacks.com
Thursday, December 30, 2010 - 10:59am
tags:
Theravance, GSK
ZIOP Initiates Cancer Study
Yahoo/Zacks.com
Thursday, December 30, 2010 - 10:58am
tags:
Ziopharm, cancer, palifosfamide, Allos
Sucampo buys Swiss patent-holding company
Bizjournals.com
Thursday, December 30, 2010 - 10:56am
tags:
Sucampo, M&A
FDA OKs Endo Pharmaceuticals' testosterone gel
Yahoo/AP
Thursday, December 30, 2010 - 10:55am
tags:
Endo, testosterone, FDA, Fortesta
The Painful Death of a Promising Drug Class
Motley Fool
Thursday, December 30, 2010 - 10:53am
tags:
Regeneron, Sanofi, JNJ, AstraZeneca, NGF-1
Pfizer buys Synbiotics for undisclosed amount
Yahoo/AP
Wednesday, December 29, 2010 - 5:59pm
tags:
animal health, Pfizer, Synbiotics, M&A
The Most Promising Dividends in Pharmaceuticals
Motley Fool
Wednesday, December 29, 2010 - 11:48am
tags:
dividends, Eli Lilly, GSK, Bristol-Myers Squibb, Pfizer, Merck, Abbott Laboratories, JNJ, Merdian, Sanofi, Novartis, AstraZeneca, Teva Pharmaceuticals, Novo Nordisk
Will Genomic Health's Next Quarter Be a Bomb?
Motley Fool
Wednesday, December 29, 2010 - 11:39am
tags:
Genomic Health

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.